Imaging Characteristics of Recently Diagnosed Pancreatic Cancer Experience at University Clinical Centre of Kosova (2011-2014)
[1]
Dedushi Kreshnike, Department of Radiology, Diagnostic Centre, UCCK, Prishtina City, Kosovo; Faculty of Medicine, Prishtina University, Prishtina City, Kosovo.
[2]
Kabashi Serbeze, Department of Radiology, Diagnostic Centre, UCCK, Prishtina City, Kosovo; Faculty of Medicine, Prishtina University, Prishtina City, Kosovo.
[3]
Hoxhaj Astrit, Hospita Hygea, Tirana City, Albania.
[4]
Ahmetgjekaj Ilir, Department of Radiology, Diagnostic Centre, UCCK, Prishtina City, Kosovo; Faculty of Medicine, Prishtina University, Prishtina City, Kosovo.
[5]
Biçaku Ardian, Department of Radiology, Diagnostic Centre, UCCK, Prishtina City, Kosovo; Faculty of Medicine, Prishtina University, Prishtina City, Kosovo.
[6]
Muçaj Sefedin, Faculty of Medicine, Prishtina University, Prishtina City, Kosovo.
[7]
Hasbahta Gazmend, Department of Radiology, Diagnostic Centre, UCCK, Prishtina City, Kosovo.
[8]
Kabashi Antigona, Department of Radiology, Diagnostic Centre, UCCK, Prishtina City, Kosovo; Faculty of Medicine, Prishtina University, Prishtina City, Kosovo.
[9]
Shatri Jeton, Department of Radiology, Diagnostic Centre, UCCK, Prishtina City, Kosovo; Faculty of Medicine, Prishtina University, Prishtina City, Kosovo.
Aim of the paper: The aim of this paper is to evaluate our experience of imaging characteristics of recently diagnosed pancreatic cancers at University Clinical Center of Kosovo. We evaluated incidence of the pancreatic cancers, distant metastases and other local infiltration signs among the total cases of the pancreatic cancers diagnosed in the University Clinical Center of Kosovo, with the aim to compare these research findings to similar studies made in the developed countries. This is a retrospective research study done during the period of 2011-2014. Materials and Methodology: This retrospective research study includes 97 patients recently diagnosed with pancreatic cancer, examined in the period of 2011-2014 at the University Clinical Center of Kosovo. The imaging diagnostics are performed with MSCT Sensation 64 Siemens, MSCT Emotion 6 Siemens, and 1.5T MRI Symphony Siemens, in the Radiologic Clinic of UCCK; while the histopathology diagnostics has been performed in Clinic of Pathology at UCCK. Results: Out of a total of the 97 patients diagnosed with pancreas cancer, 76 cases resulted in head and neck 79.4 % (n=76), 20 cases resulted in body and tail cancers (21%), 1 cases resulted metastasis in pancreas by carcinoma in colon, distant metastases in first imaging modality were found in(n=42) patients 43.3 %, local infiltration was found in patients: gastric infiltration (n=15), duodenal and papilla infiltration (n=26), local infiltration spleen (n=2), local infiltration mesentery ( n= 43), dilated biliary tree (n=34), regional lymph node infiltration (n=83). Out of a total of the 97 patients diagnosed with pancreas cancer ,85 cases resulted > 2 cm and 11 cases resulted < 2 cm and with component cystic was 41.2 %( n = 40), solid with component cystic – necrotic 33% (n=32), solid 25.8% (n=25). Discussion and Conclusions: Seventy-four percent (74%, n=72) of all cancers are found in Stage III and IV. From an imaging point of view, these cancers were presented in an advanced stage, mainly due to their late clinical symptoms and limited access to imaging methods in our country.
Pancreatic Cancer, MSCT, MRI, Distant Metastasis, Local Infiltration, University Clinical Center of Kosovo, Prishtina, Kosovo
[1]
Pancreatic Cancer imaging : Which Method by E.Santo - 2004 http://springpublishing.org/index.php/APCI/article/view/4`
[2]
Common and unusual CT and MRI manifestations of pancreatic adenocarcinoma: a pictorial review Min-Jie Yang, Su Li, Yong-Guang Liu, Na Jiao, and Jing-Shan Gong Quant Imaging Med Surg. 2013 Apr; 3(2): 113–120. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636472/
[3]
Pancreatic imaging mimics: part 1, imaging mimics of pancreatic adenocarcinoma. Coakley FV1, Hanley-Knutson K, Mongan J, Barajas R, Bucknor M, Qayyum A. AJR Am J Roentgenol. 2012 Aug;199(2):301-8. doi: 10.2214/AJR.11.7907 http://www.ncbi.nlm.nih.gov/pubmed/22826390
[4]
Pancreatic imaging mimics: part 2, pancreatic neuroendocrine tumors and their mimics. Raman SP1, Hruban RH, Cameron JL, Wolfgang CL, Fishman EK.AJR Am J Roentgenol. 2012 Aug; 199(2):309-18. doi: 10.2214/AJR.12.8627. http://www.ncbi.nlm.nih.gov/pubmed/22826391
[5]
Mimics of pancreatic ductal adenocarcinomaMahmoud M. Al-Hawary, Xa Ravi K. Kaza,a Shadi F. Azar,a,b Julie A. Ruma,a,b and Isaac R. Francisa Cancer Imaging. 2013; 13(3): 342–349. Published online 2013 Sep 23. doi: 10.1102/1470-7330.2013.9012 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800430/
[6]
American Cancer Society What are the key statistics about pancreatic cancer? 2011 Jun 21. In: Pancreatic Cancer [Internet]. American Cancer Society, Inc. c2011. Available from:http://www.cancer.org/cancer/pancreaticcancer/detailedguide/pancreatic-cancer-key-statistics.
[7]
Lynch SM, Vrieling A, Lubin JH, Kraft P, Mendelsohn JB, Hartge P, et al. Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol. 2009;170:403–13.[PMC free article] [PubMed]
[8]
Tersmette AC, Petersen GM, Offerhaus GJ, Falatko FC, Brune KA, Goggins M, et al. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res.2001;7:738–44. [PubMed
[9]
Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med. 1993;328:1433–7.[PubMed]
[10]
Kalser MH, Barkin J, MacIntyre JM. Pancreatic cancer. Assessment of prognosis by clinical presentation.Cancer. 1985;56:397–402. [PubMed]
[11]
Chang MC, Su CH, Sun MS, Huang SC, Chiu CT, Chen MC, et al. Etiology of acute pancreatitis--a multi-center study in Taiwan. Hepatogastroenterology. 2003;50:1655–. [PubMed]
[12]
Calle EE, Murphy TK, Rodriguez C, Thun MJ, Heath CW., Jr Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults. Cancer Causes Control. 1998;9:403–10. [PubMed]
[13]
Schima W, Ba-Ssalamah A, Kölblinger C, Kulinna-Cosentini C, Puespoek A, Götzinger P. Pancreatic adenocarcinoma. Eur Radiol. 2007;17:638–649. [PubMed
[14]
Imaging diagnosis of pancreatic cancer: A state-of-the-art reviewEun Sun Lee and Jeong Min Lee World J Gastroenterol. 2014 Jun 28; 20(24): 7864–7877.Published online 2014 Jun 28 doi:10.3748/wjq.v20.i24.7864: //www.ncbi.nlm.nih.gov/pmc/articles/PMC4069314/
[15]
Rickes S, Unkrodt K, Neye H, Ocran KW, Wermke W. Differentiation of pancreatic tumours by conventional ultrasound, unenhanced and echo-enhanced power Doppler sonography. Scand J Gastroenterol.2002;37:1313–20. [PubMed]
[16]
Catalano C, Laghi A, Fraioli F, Pediconi F, Napoli A, Danti M, et al. Pancreatic carcinoma: the role of high-resolution multislice spiral CT in the diagnosis and assessment of resectability. Eur Radiol. 2003;13:149–56.[PubMed]
[17]
Vargas R, Nino-Murcia M, Trueblood W, Jeffrey RB., Jr MDCT in Pancreatic adenocarcinoma: prediction of vascular invasion and resectability using a multiphasic technique with curved planar reformations. AJR Am J Roentgenol. 2004;182:419–25. [PubMed]
[18]
Miura F, Takada T, Amano H, Yoshida M, Furui S, Takeshita K. Diagnosis of pancreatic cancer. HPB (Oxford) 2006;8:337–42. [PMC free article] [PubMed]
[19]
Palazzo L, Roseau G, Gayet B, Vilgrain V, Belghiti J, Fékéte F, et al. Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma. Results of a prospective study with comparison to ultrasonography and CT scan. Endoscopy. 1993;25:143–150. [PubMed]
[20]
Ichikawa T, Haradome H, Hachiya J, Nitatori T, Ohtomo K, Kinoshita T, et al. Pancreatic ductal adenocarcinoma: preoperative assessment with helical CT versus dynamic MR imaging. Radiology.1997;202:655–62. [PubMed]
[21]
Prokesch RW, Chow LC, Beaulieu CF, Bammer R, Jeffrey RB., Jr Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs. Radiology. 2002;224:764–8. [PubMed]
[22]
Ahualli J. The double duct sign. Radiology. 2007;244:314–5. [PubMed]
[23]
Karmazanovsky G, Fedorov V, Kubyshkin V, Kotchatkov A. Pancreatic head cancer: accuracy of CT in determination of resectability. Abdom Imaging. 2005;30:488–500. [PubMed]
[24]
Roche CJ, Hughes ML, Garvey CJ, Campbell F, White DA, Jones L, et al. CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas. AJR Am J Roentgenol. 2003; 180:475–80. [PubMed]
[25]
Andersson R, Vagianos CE, Williamson RC. Preoperative staging and evaluation of resectability in pancreatic ductal adenocarcinoma. HPB (Oxford) 2004;6:5–12. [PMC free article] [PubMed]
[26]
Takakura K, Sumiyama K, Munakata K, Ashida H, Arihiro S, Kakutani H, et al. Clinical usefulness of diffusion-weighted MR imaging for detection of pancreatic cancer: comparison with enhanced multidetector-row CT. Abdom Imaging. 2011;36:457–62. [PubMed]
[27]
Adamek HE, Albert J, Breer H, Weitz M, Schilling D, Riemann JF. Pancreatic cancer detection with magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography: a prospective controlled study. Lancet. 2000;356:190–3. [PubMed]
[28]
Varghese JC, Farrell MA, Courtney G, Osborne H, Murray FE, Lee MJ. Role of MR cholangiopancreatography in patients with failed or inadequate ERCP. AJR Am J Roentgenol. 1999;173:1527–33. [PubMed]
[29]
Johnson PT, Outwater EK. Pancreatic carcinoma versus chronic pancreatitis: dynamic MR imaging.Radiology. 1999;212:213–8. [PubMed]
[30]
Ichikawa T, Sou H, Araki T, Arbab AS, Yoshikawa T, Ishigame K, et al. Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology. 2001;221:107–16. [PubMed]
[31]
European cancer mortality predictions for the year 2012 M. Malvezzi1,2, P. Bertuccio1,2, F. Levi3, C. La Vecchia1,2,* and E. Negri1 Ann Oncol (2012) doi: 10.1093/annonc/mds024 First published online: February 28, 2012 http://annonc.oxfordjournals.org/content/early/2012/02/24/annonc.mds024.short
[32]
Pancreatic cancer mortality in Serbia from 1991- 2010 a joinpoint analysis. Milena Ilic , Hristina Vlajinac, Jelena Marinkovic and Nikola Kocev Croat Med J. 2013 Aug; 54(4): 369–375. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3760661/
[33]
www.cancerresearchuk.org, http://www.cancerresearchuk.org/cancer-info/cancerstats/types/pancreas/mortality/
[34]
Pancreatic Cancer: An Endoscopic Perspective: Diagnosis & Staging of Pancreatic Cancer Shounak Majumder, MD; Saman Chubineh, MD; John Birk, MD Faculty and DisclosuresCME Released: 12/09/2011; Valid for credit through12/09/2012 http://www.medscape.org/viewarticle/754555_2
[35]
Management of adenocarcinoma of the body and tail of the pancreas. M F Brennan, R D Moccia, and D Klimstra Ann Surg. 1996 May; 223(5): 506–512 PMCID: PMC1235171 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1235171/
[36]
Pancreatic tumors: role of imaging in the diagnosis, staging, and treatment Dominique Delbeke1 and C. Wright Pinson2 J Hepatobiliary Pancreat Surg (2004) 11:4–10 DOI 10.1007/s00534-002-0775-x http://www.csee.usf.edu/~manohar/Papers/Pancreas/pancreatic%20staging.pdf
[37]
Multidetector CT of the Pancreas Raj Mohan Paspulati, MDNovember 2005 volume 43, Issue 6, Pages 999-1020 http://www.radiologic.theclinics.com/article/S0033-8389(05)00097-7/fulltext
[38]
McNulty,N.J.Francis,I.F. et al, Multi- detector row heliac CT of the pancreas: effect of contrast- enhanced multiphasic imaging on enchancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma. Radiology. 2001:220:97-102. PubMed
[39]
Evaluation of focal pancreatic masses: comparison of mangafodipir-enhanced MR imaging and contrast-enhanced helical CT. Schima W1, Függer R. Eur Radiol. 2002 Dec;12(12):2998-3008. Epub 2002 Jul 12. [PubMed - indexed for MEDLINE
